Video

Mark R. Gilbert Discusses Glioblastoma Research

Author(s):

Mark R. Gilbert

CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

Mark R. Gilbert, senior investigator, chief, Neuro-Oncology Branch, National Cancer Institute, discusses the need for collaboration in glioblastoma research. CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Image of Kumar.
Related Content
FDA sign.
April 23rd 2025

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

Ryan Scott
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Illustration of brain.
April 16th 2025

TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma

Ryan Scott
TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
Illustration of brain.
April 4th 2025

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Ryan Scott
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.